Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Atypical presentations of SLE including unusual initial symptoms, predominant organ involvement, late-onset disease and ANA-negative remain poorly characterized. These forms are often associated with delayed diagnosis and potentially worse clinical outcomes. Most existing studies focus on isolated rare manifestations rather than analyzing atypical SLE as a cohesive category. Understanding these differences is crucial and this study aims to compare atypical and typical SLE presentations to clarify variations in prognosis, treatment requirements and subsequent organ involvement.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| systemic lupus erythematosus patients with typical presentations | |||
| Systemic lupus erythematosus patients with atypical presentations |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Disease activity measured by SLEDAI-2K score | SLEDAI-2K score will be calculated for each participant. Data will be reported as mean ± SD and compared between patients with typical and atypical SLE presentations | Baseline (0 month), 6 months, 12 months |
| Organ damage accrual measured by SDI score | Systemic Lupus International Collaborating Clinics Damage Index (SDI) will be assessed to evaluate irreversible organ damage. Data will be reported as mean ± SD and compared between patients with typical and atypical SLE presentations | 6 months, 12 months |
Not provided
Not provided
Inclusion Criteria:
Patients diagnosed as SLE according toSLICC 2012Classification Criteria[13] :
A. Patients presented with typical lupus presentation:
B. Patients presented with atypical lupus presentation:
any clinical presentation not belonging to classic common SLE onset features, including but not limited to:
Patients with dominant organ affection.
patients with late onset SLE.
patients with ANA negative SLE. C.Patients who can provide informed consent.
exclusion criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
The study will include 400 patients diagnosed according to SLICC classification criteria as systemic lupus erythematosus[13] including 3oo patients with typical common SLE presentation and 100 patients with atypical presentation as rare manifestations,ANA negative lupus, late onset lupus.Patients will be collected from Rheumatology outpatient clinic - Sohag University Hospital.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yasmine Fatah Mohamed, MD | Contact | 01032071095 | 01106191664 | yasmine_abdelfattah_post@med.sohag.edu.eg |
| Ahmed Mohamed Mahrous, professor | Contact | 01009323356 |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sohag university hospitals,sohag ,sohag | Sohag | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Dec 7, 2025 | Jan 9, 2026 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D008180 | Lupus Erythematosus, Systemic |
| ID | Term |
|---|---|
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided